
Opinion|Videos|March 21, 2025
Integrating Bispecific Antibodies in Community Oncology: Benefits and Considerations
Experts discuss the benefits of implementing and operationalizing bispecifics in the community oncology setting.
Advertisement
Episodes in this series

Video content above is prompted by the following:
What are the benefits of implementing/operationalizing bispecifics in the community oncology setting?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Mirvetuximab Soravtansine Demonstrates Promising Efficacy, Safety in Platinum-Resistant Recurrent Ovarian Cancer
2
How Artificial Intelligence Is Transforming Leukemia Detection and Diagnosis
3
Long-Term Remission in Ph-Negative B-ALL With Sequential CAR T, ASCT
4
Zanubrutinib Shows Similar Efficacy but Better Safety Than VEN–I in Frontline CLL
5














































